Focal, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Modular premarket approval submission for the FocalSeal-L surgical sealant for use in lung surgery begins Jan. 6. The company hopes to expand indications for the liquid, synthetic sealant for use in pulmonary surgery, neurosurgery, cardiovascular and gastrointestinal surgery